NCT03848416View on ClinicalTrials.gov

A Study of Ixekizumab in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

June 7, 2019

Study Completion Date

June 7, 2019

Conditions
Healthy
Interventions
BIOLOGICAL

Ixekizumab

Administered SC

Trial Locations (1)

32117

Covance Clinical Research Inc, Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03848416 - A Study of Ixekizumab in Healthy Participants | Biotech Hunter | Biotech Hunter